skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v1.9

Opposition

Number:91237171Filing Date:10/11/2017
Status:TerminatedStatus Date:02/28/2018
General Contact Number:571-272-8500
Interlocutory Attorney:MIKE WEBSTER
Paralegal Name:JOI WILSON
Defendant
Name:AstraZeneca AB
Correspondence:DAVID M KELLY
KELLY IP LLP
1919 M STREET N W, SUITE 610
WASHINGTON, DC 20036
UNITED STATES
david.kelly@kelly-ip.com, linda.mcleod@kelly-ip.com, jason.joyal@kelly-ip.com
Phone: 202-808-3570
 
Serial #:87128498Application FileAssignmentRegistration #:5612391
Application Status: Registered
Mark: FASENRA
Plaintiff
Name:Jazz Pharmaceuticals, Inc.
Correspondence:TIFFANY A BLOFIELD
WINTHROP & WEINSTINE P A
225 SOUTH SIXTH STREET, SUITE 3500
MINNEAPOLIS, MN 55402
UNITED STATES
Tblofield@winthrop.com, Sbaird@winthrop.com, Trademark@winthrop.com, cclassen@winthrop.com, ayoung@winthrop.com, greyes@winthrop.com
Phone: 612-604-6684
 
Serial #:78170707Application FileAssignmentRegistration #:2902272
Application Status: REGISTERED AND RENEWED
Mark: FAZACLO
 
Serial #:78411481Application FileAssignmentRegistration #:3146363
Application Status: REGISTERED AND RENEWED
Mark: FAZACLO (CLOZAPINE, USP) ORALLY DISINTEGRATING TABLETS
Prosecution History
#DateHistory TextDue Date
902/28/2018TERMINATED
802/28/2018BD DECISION: DISMISSED W/ PREJ
702/16/2018W/DRAW OF OPPOSITION
612/28/2017ANSWER TO COUNTERCLAIM
511/28/2017ANSWER TO COUNTERCLAIM DUE (DUE DATE)12/28/2017
411/17/2017ANSWER AND COUNTERCLAIM (FEE)
310/11/2017PENDING, INSTITUTED
210/11/2017NOTICE AND TRIAL DATES SENT; ANSWER DUE:11/20/2017
110/11/2017FILED AND FEE
Results as of 01/23/2020 02:21 AM
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY